Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Spore.Bio logo — AI + Light for Microbiology

Spore.Bio

AI + Light for Microbiology

Founded 2023 France France 70 employees Series A Total: $31.00M Industrial, Information Technology +1

General Information

Company Name Spore.Bio
Founded Year 2023
Location France France
Employees 70
Industries Industrial, Information Technology, Manufacturing
Funding Stage Series A
Business Model B2B, SaaS, D2C
Revenue Model Subscription, Usage Based, Service Fee
Social

BounceWatch is an independent company data service, not affiliated with Spore.Bio. To contact Spore.Bio, visit spore.bio.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Spore.Bio compare?

A PDF of Spore.Bio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Spore.Bio soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Spore.Bio

Spore.Bio, founded in 2023, is at the forefront of combining AI and light for innovations in microbiology, setting the stage for a new era in microbiological technologies. Their novel approach positions them uniquely in the intersecting sectors of Industrial, Information Technology, and Manufacturing.

Headquartered in France, Spore.Bio recently secured a $23.00M Series A investment on 20 February 2025, demonstrating strong investor confidence. This round attracted attention from esteemed investors, including No Label Ventures, Famille C., Point 72 Ventures, STATION F, Singular, 1st Kind Ventures, Lord David Prior, and LocalGlobe.

The company's slogan, "AI + Light for Microbiology," encapsulates its mission to redefine the microbiological landscape through technology. With strong investor backing and a distinctive technological proposition, they are well-positioned for growth and could be a promising opportunity for investors seeking to capitalize on cutting-edge industrial innovation.

Business keywords: AI-driven microbiology, Microbiological technologies, Biotechnology manufacturing, Product safety innovation, Bacterial resistance solutions, Climate change tools, Globalization adaptation, Consumer behavior technology, Sustainable manufacturing, Microbiological research, Innovative technological tools, Spore formation study, Biotechnology startups, Health and safety compliance

Services & Products

AI-powered microbial detection
Direct Method quantification and identification
Real-time data integration
Spectral imaging technology

Target Customers

Water and environment industry Beverage industry Cosmetics industry Pharmaceutical industry Cell and gene therapy companies Food industry

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $23.00M 8
No Label Ventures Famille C. Point 72 Ventures
No Label Ventures, Famille C. +6
20 Feb 2025
Pre Seed Round €8.00M 10
Kima Ventures No Label Ventures EmergingTech Ventures
Kima Ventures, No Label Ventures +8
12 Dec 2023
Non Equity Assistance Undisclosed 1
AGORANOV
AGORANOV
01 Mar 2023

Latest News

View All
French BioTech Spore.Bio secures multi-million-dollar Google.org funding and launches AI-native rese... — Eu-startups
French BioTech Spore.Bio secures multi-million-dollar Google.org funding and launches AI-native research unit
Eu-startups Jan 08, 2026
Spore.Bio secures $23M Series A for on-site microbiology testing — Tech
Spore.Bio secures $23M Series A for on-site microbiology testing
Tech Feb 20, 2025
Yapay zeka destekli mikrobiyoloji testleri geliştiren Spore.Bio, 23 milyon dolar yatırım aldı — Webrazzi
Yapay zeka destekli mikrobiyoloji testleri geliştiren Spore.Bio, 23 milyon dolar yatırım aldı
Webrazzi Feb 20, 2025
Spore.Bio raises €22 million to deploy a new generation of AI-based microbiology testing — Eu-startups
Spore.Bio raises €22 million to deploy a new generation of AI-based microbiology testing
Eu-startups Feb 20, 2025
The Hottest Startups in Paris in 2024 — Wired
The Hottest Startups in Paris in 2024
Wired Oct 15, 2024
Join the future of grocery innovation: The Growing Further Awards are now open for applications (Spo... — Eu-startups
Join the future of grocery innovation: The Growing Further Awards are now open for applications (Sponsored)
Eu-startups Sep 13, 2024

Spore.Bio Alternatives & Competitors

View All Alternatives
Spore.Bio vs
bNovate Technologies SA
bNovate Technologies SA Switzerland

Rapid and automated online bacteria monitoring in drinking water for SAFE WATER. ANYTIME. ANYWHERE.

Series C
42 employees
Automation, Biotechnology
Compare Spore.Bio vs bNovate Technologies SA
Spore.Bio vs
SMF Maschinenfabrik GmbH
SMF Maschinenfabrik GmbH Germany

Let us be part of Your Success Story!

16 employees
Industrial, Manufacturing
Compare Spore.Bio vs SMF Maschinenfabrik GmbH
Spore.Bio vs
ISC Gums
ISC Gums United States

The leading manufacturer of Gum Acacia and developer of Fusion stabilizer and texturizer systems.

11 employees
Food and Beverage, Industrial
View all alternatives

FAQ About Spore.Bio

AI + Light for Microbiology
Spore.Bio was founded in 2023.
Spore.Bio is headquartered in France.
Spore.Bio operates in Industrial, Information Technology and Manufacturing. Its work centres on AI-driven microbiology, Microbiological technologies, Biotechnology manufacturing and Product safety innovation. Its customers include Water and environment industry, Beverage industry and Cosmetics industry.
Spore.Bio has a B2B, SaaS and D2C business model. Its revenue comes from Subscription, Usage Based and Service Fee.
Spore.Bio has approximately 70 employees.
Spore.Bio has completed 3 funding rounds, raising a total of $31.00M. The latest funding stage is Series A.
Spore.Bio offers: AI-powered microbial detection, Direct Method quantification and identification, Real-time data integration, Spectral imaging technology.
Top alternatives and competitors to Spore.Bio include bNovate Technologies SA, SMF Maschinenfabrik GmbH, ISC Gums, Visiomex, Steck. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Spore.Bio and bNovate Technologies SA are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Spore.Bio, https://bouncewatch.com/company/sporebio, updated 14 May 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes